# EDGAR Filing Document

**Accession Number:** 0001209466
**File Stem:** 0001752724-25-161231
**Filing Date:** 2025-6
**Character Count:** 17048
**Document Hash:** 75141ff6bd64525fa0227c264ebf4833
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-161231.hdr.sgml**: 20250627

**ACCESSION NUMBER**: 0001752724-25-161231

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250430

**FILED AS OF DATE**: 20250627

**DATE AS OF CHANGE**: 20250627

**PERIOD START**: 20250430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVESCO EXCHANGE-TRADED FUND TRUST
- **CENTRAL INDEX KEY:** 0001209466

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21265
- **FILM NUMBER:** 251082978

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POWERSHARES EXCHANGE TRADED FUND TRUST
- **DATE OF NAME CHANGE:** 20021210

## Series and Classes Contracts Data

### Invesco Dorsey Wright Healthcare Momentum ETF (Series ID: S000013104)

| Class ID   | Class Name                                    | Ticker Symbol   |
|:---|:---|:---|
| C000035320 | Invesco Dorsey Wright Healthcare Momentum ETF | PTH             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-21265

- **c. CIK number of Registrant:** 0001209466

- **d. LEI of Registrant:** QPT4TMG79RF3UWNU0R52

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco Dorsey Wright Healthcare Momentum ETF

- **b. EDGAR series identifier (if any):** S000013104

- **c. LEI of Series:** 549300HW4X5F66JYEL71

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-04-30

- **b. Date as of which information is reported:** 2025-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $144301631.00

**Total Liabilities:** $35557019.13

**Net Assets:** $108744611.87

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000035320 | -3.69%               | -5.17%               | 1.78%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $0.00                    | $-4664146.08                               |
| Month 2  | $312498.22               | $-6581169.13                               |
| Month 3  | $4629228.60              | $-3048741.29                               |

### Schedule of Portfolio Investments

| Name                                  | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Masimo Corp.                          | Masimo Corp.                                               | CUSIP: 574795100<br>LEI: 549300Q4A8JK0PIYCU29 | Long             | EC               | CORP              | US        |     16211 | NS      | $2609322.56   | 2.40%             |  |  |  | No            |                  1 | On Loan: —       |
| Insmed Inc.                           | Insmed Inc.                                                | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     47875 | NS      | $3447000.00   | 3.17%             |  |  |  | No            |                  1 | On Loan: —       |
| Axsome Therapeutics, Inc.             | Axsome Therapeutics, Inc.                                  | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     32050 | NS      | $3598894.50   | 3.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly and Co.                     | Eli Lilly and Co.                                          | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      5160 | NS      | $4638582.00   | 4.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Axogen, Inc.                          | Axogen, Inc.                                               | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    156421 | NS      | $2544969.67   | 2.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings, Inc.        | Xeris Biopharma Holdings, Inc.                             | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    464966 | NS      | $2124894.62   | 1.95%             |  |  |  | No            |                  1 | On Loan: —       |
| Cencora, Inc.                         | Cencora, Inc.                                              | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |     15892 | NS      | $4651111.64   | 4.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems, Inc.           | Merit Medical Systems, Inc.                                | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |     33351 | NS      | $3150001.95   | 2.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Anavex Life Sciences Corp.            | Anavex Life Sciences Corp.                                 | CUSIP: 032797300<br>LEI: 549300K1I5L8COCQ8W36 | Long             | EC               | CORP              | US        |    245545 | NS      | $2332677.50   | 2.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Boston Scientific Corp.               | Boston Scientific Corp.                                    | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |     38756 | NS      | $3986829.72   | 3.67%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc.                           | AbbVie Inc.                                                | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     17457 | NS      | $3405860.70   | 3.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis, Inc.                        | Exelixis, Inc.                                             | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    112750 | NS      | $4414162.50   | 4.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics, Inc.           | Halozyme Therapeutics, Inc.                                | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |     38197 | NS      | $2346059.74   | 2.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech, Inc.                 | Krystal Biotech, Inc.                                      | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |     21179 | NS      | $3597888.52   | 3.31%             |  |  |  | No            |                  1 | On Loan: —       |
| Mineralys Therapeutics, Inc.          | Mineralys Therapeutics, Inc.                               | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    140029 | NS      | $1989812.09   | 1.83%             |  |  |  | No            |                  1 | On Loan: —       |
| Ocular Therapeutix, Inc.              | Ocular Therapeutix, Inc.                                   | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |    335069 | NS      | $2781072.70   | 2.56%             |  |  |  | No            |                  1 | On Loan: —       |
| 908 Devices Inc.                      | 908 Devices Inc.                                           | CUSIP: 65443P102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    538908 | NS      | $2926270.44   | 2.69%             |  |  |  | No            |                  1 | On Loan: —       |
| agilon health, Inc.                   | agilon health, Inc.                                        | CUSIP: 00857U107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    551528 | NS      | $2349509.28   | 2.16%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcutis Biotherapeutics, Inc.         | Arcutis Biotherapeutics, Inc.                              | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    176977 | NS      | $2638727.07   | 2.43%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Private Prime Fund            | Invesco Private Prime Fund                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  25531198 | NS      | $25531198.22  | 23.48%            |  |  |  | No            |                  2 | On Loan: No      |
| Trevi Therapeutics, Inc.              | Trevi Therapeutics, Inc.                                   | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    431965 | NS      | $2984878.15   | 2.74%             |  |  |  | No            |                  1 | On Loan: —       |
| PTC Therapeutics, Inc.                | PTC Therapeutics, Inc.                                     | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |     55529 | NS      | $2767565.36   | 2.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Phreesia, Inc.                        | Phreesia, Inc.                                             | CUSIP: 71944F106<br>LEI: 5493000HHF8NU4QOCG53 | Long             | EC               | CORP              | US        |     76448 | NS      | $1908142.08   | 1.75%             |  |  |  | No            |                  1 | On Loan: —       |
| uniQure N.V.                          | uniQure N.V.                                               | CUSIP: N90064101<br>LEI: 724500RPCTZLFYJZ3S98 | Long             | EC               | CORP              | NL        |    190447 | NS      | $2810997.72   | 2.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings, Inc.               | Lantheus Holdings, Inc.                                    | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |     30140 | NS      | $3144807.60   | 2.89%             |  |  |  | No            |                  1 | On Loan: No      |
| BridgeBio Pharma, Inc.                | BridgeBio Pharma, Inc.                                     | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     98763 | NS      | $3788548.68   | 3.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Catalyst Pharmaceuticals, Inc.        | Catalyst Pharmaceuticals, Inc.                             | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |    117101 | NS      | $2844383.29   | 2.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health, Inc.                 | Guardant Health, Inc.                                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     79520 | NS      | $3755729.60   | 3.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Organogenesis Holdings Inc.           | Organogenesis Holdings Inc.                                | CUSIP: 68621F102<br>LEI: 549300RLC2O821TU6941 | Long             | EC               | CORP              | US        |    446741 | NS      | $2193498.31   | 2.02%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    249261 | NS      | $249261.34    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics, Inc.                 | TG Therapeutics, Inc.                                      | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     98264 | NS      | $4471994.64   | 4.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Private Government Fund       | Invesco Private Government Fund                            | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |   9815269 | NS      | $9815269.28   | 9.03%             |  |  |  | No            |                  2 | On Loan: No      |
| Alignment Healthcare, Inc.            | Alignment Healthcare, Inc.                                 | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    216273 | NS      | $3832357.56   | 3.52%             |  |  |  | No            |                  1 | On Loan: —       |
| ResMed Inc.                           | ResMed Inc.                                                | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     14971 | NS      | $3541988.89   | 3.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics, Inc.        | Protagonist Therapeutics, Inc.                             | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     64510 | NS      | $2955848.20   | 2.72%             |  |  |  | No            |                  1 | On Loan: —       |
| Amneal Pharmaceuticals, Inc.          | Amneal Pharmaceuticals, Inc.                               | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |    329608 | NS      | $2524797.28   | 2.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp.                        | Liquidia Corp.                                             | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |    145098 | NS      | $2027019.06   | 1.86%             |  |  |  | No            |                  1 | On Loan: —       |
| Madrigal Pharmaceuticals, Inc.        | Madrigal Pharmaceuticals, Inc.                             | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |     10699 | NS      | $3572503.09   | 3.29%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2025-05-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President